Phase II Study of Tesetaxel in Metastatic Melanoma

Clinical trial NCT01064713 · COMPLETED

Trial details

NCT number: NCT01064713
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Melanoma Cancer

Start date: 2010-02-01
Primary completion: 2014-10-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.